Jubilant, Gilead ink pact for Remdesivir
4 years, 7 months ago

Jubilant, Gilead ink pact for Remdesivir

The Hindu  

Jubilant Life Sciences, through a subsidiary, has entered into a non-exclusive licensing agreement with Gilead Sciences Inc. to register, manufacture and sell Gilead’s Remdesivir, a potential therapy for COVID-19 in 127 countries, including India. Jubilant Life Sciences chairman Shyam S.Bhartia and co-chairman and MD Hari S. Bhartia said Remdesivir, based on initial data, showed promise as a potential therapy for COVID-19. We also plan to produce the drug’s active pharmaceutical ingredient in-house helping its cost effectiveness and consistent availability.” An investigational anti-viral therapy developed by Gilead, Remdesivir received Emergency Use Authorisation by the US Food and Drug Administration to treat COVID-19. The EUA was based on available data from two global clinical trials – U.S. National Institute for Allergy and Infectious Diseases’ placebo-controlled Phase 3 study in patients with moderate to severe symptoms of COVID-19 and Gilead’s global Phase 3 study evaluating Remdesivir in patients with severe disease.

Gilead Remdesivir Jubilant Life Sciences  severe  countries  remdesivir  pact  ink  covid19  sciences  jubilant  trials  regulatory  gilead  patients  therapy

History of this topic

Gilead Put Lives before Profits! Says AHF INDIA
1 year, 6 months ago

Gilead Put Lives before Profits! Says AHF INDIA

Deccan Chronicle  

Gilead Sciences Inc. is among the top 15 largest biopharmaceutical firms in the world, generating over $27 billion in revenue and paying its CEO over $19 million in 2021 alone. AHF - AIDS HEALTHCARE FOUNDATION, continues pressuring, pharmaceutical giant Gilead Sciences to stop its greedy tactics and put lives before profits, Gilead is one of the worst offenders of big …

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 11 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply
2 years, 8 months ago

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply

News 18  

On April 2, the World Health Organization suspended the supply of Bharat Biotech’s Covaxin through the UN agencies after finding issues with the “good manufacturing practices”. For the past 15 days, not only health journalists, but even commoners who got Covaxin jabs are hoping to hear from the country’s drug regulatory agency – Central Drugs Standard Control Organization. Eventually, the …

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel
2 years, 9 months ago

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel

News 18  

Why none of the pharmaceutical public sector units were not granted a licence to produce Remdesivir when the common man was facing “hardships” in procuring the anti-Covid drug during the second wave, the parliamentary standing committee on chemicals and fertilizers has made an observation in its report. “However, the committee failed to understand that none of the Pharma Public Sector …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
2 years, 11 months ago

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids

Firstpost  

According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with COVID-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’
3 years ago

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’

CNN  

Washington CNN — President Joe Biden on Tuesday praised Pfizer’s report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms. “I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective at reducing the …

Merck’s COVID-19 pill narrowly wins FDA panel’s support
3 years, 1 month ago

Merck’s COVID-19 pill narrowly wins FDA panel’s support

LA Times  

An FDA panel voted 13 to 10 to recommend authorization of Merck’s experimental COVID-19 drug, molnupiravir, on Tuesday — with many caveats. Harvard infectious disease specialist Dr. Lindsey R. Baden, who chairs the FDA advisory committee, called molnupiravir’s apparent effectiveness “wobbly.” He said his own decision to recommend that the FDA grant emergency-use authorization was “incredibly difficult” in light of …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 2 months ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 2 months ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 2 months ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

Merck seeks first US authorization for Covid-19 tablet
3 years, 2 months ago

Merck seeks first US authorization for Covid-19 tablet

Live Mint  

Merck & Co Inc said on Monday it has applied for US emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease. An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken …

Merck seeks US authorisation for pill to treat COVID
3 years, 2 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

Explained | Molnupiravir, Merck’s new drug to treat COVID-19
3 years, 3 months ago

Explained | Molnupiravir, Merck’s new drug to treat COVID-19

The Hindu  

Why is there much excitement about molnupiravir, the investigational new drug for COVID-19? Pharmaceutical major Merck and Ridgeback Biotherapeutics announced via a press release on October 1 the early results from Phase-3 trials that its anti-viral drug molnupiravir halved the chances of hospitalisation in COVID-19 patients with mild or moderate disease. Several noted clinicians have said that these are promising …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 3 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials
3 years, 4 months ago

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Hindustan Times  

The Drugs Controller General of India has given approval to Biological E for two clinical trials of its Covid-19 vaccine candidate Corbevax, the ministry of science and technology announced Friday. The Hyderabad-based pharmaceutical company received approval for Phase 3 comparator safety and immunogenicity trial in adults after a review of Phase 1 and 2 clinical trials data by a subject …

Anti-Diabetic Drugs Have Potential to Treat Covid-19, Finds Hyderabad University Study
3 years, 6 months ago

Anti-Diabetic Drugs Have Potential to Treat Covid-19, Finds Hyderabad University Study

News 18  

Amid the rush to develop cures for the coronavirus, a study by a University of Hyderabad incubated startup, has discovered that an anti-diabetic drug has potential use as a ready to use, cost-effective solution for safely treating Covid patients. In-vitro and in-silico studies conducted by ReaGene Innovations Private Limited, a startup company incubated at the ASPIRE-BioNEST, and INDRAS Private Limited, …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19
3 years, 6 months ago

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19

Daily Mail  

The Biden administration is devoting $3.2 billion to help develop antiviral pills to treat COVID-19, officials said on Thursday. The U.S. government has committed $3.2 billion to help develop antiviral pills to treat COVID-19, officials including Dr Anthony Fauci announced on Thursday Several pills are in development that will be used to minimize symptoms of the virus early on in …

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 7 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment
3 years, 7 months ago

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment

News 18  

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care. To stop the misuse of Remdesivir, the government further recommended that if the drug is to be advised or ordered during odd hours, it should be done …

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana
3 years, 7 months ago

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana

Firstpost  

Ganga Ram hospital Chairperson Dr DS Rana said, “Medicines that do not have any activity to work, will have to be discontinued.” Ganga Ram hospital Chairperson Dr DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. While talking to …

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium
3 years, 7 months ago

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium

The Quint  

Chief Minister MK Stalin recently announced that the government will open Remdesivir counters at Madurai, Coimbatore, Trichy and Tirunelveli to address the state-wide shortage of the anti viral drug. In its submissions to the Madras HC, the state government added that it had received 250,000 vials of Remdesivir so far and the minimum requirement in the state was 20,000 vials …

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?
3 years, 7 months ago

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?

India TV News  

During COVID 19 second wave in India, a number of people are seen hunting for oxygen cylinders, ICU beds and many more medical facilities across the country. Know all about it here: According to an infographic video shared by PIB fact check, a verified Twitter account by the government of India to counter misinformation on govt. Meanwhile, India recorded 362,727 …

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say
3 years, 7 months ago

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say

India Today  

As the second wave of Covid-19 wreaks havoc across the country, the spotlight is on what India has recommended and what it hasn't for the management of adult patients. A look at India’s clinical management protocol: Covid treatment protocol for people with mild disease In the case of mild infection, upper respiratory tract symptoms like fever without shortness of breath …

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug
3 years, 7 months ago

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug

Business Standard  

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly Premium Eli Lilly logo is shown on one of the company's offices in San Diego, California. Photo: Reuters US pharma giant Eli Lilly has issued royalty-free, non-exclusive voluntary licences …

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us
3 years, 8 months ago

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us

News 18  

Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the chemist stores/pharmacies across India, were all over the newspapers. Though clinical trials have not found Remdesivir beneficial in COVID-19 treatment; however, clinicians in India and even the national COVID-19 task force and expert groups in India continue …

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
3 years, 8 months ago

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

News 18  

Cipla on Monday announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment. Baricitinib earlier received restricted emergency use approval by y the Central Drugs Standard Control Organization for use in combination with remdesivir for the treatment of hospitalized COVID-19 adult patients requiring supplemental oxygen, Cipla said. “We hope that our donations …

Covid-19: Remdesivir Allocation Made Up to May 16 to Ensure Availability, Says Union Minister
3 years, 8 months ago

Covid-19: Remdesivir Allocation Made Up to May 16 to Ensure Availability, Says Union Minister

News 18  

To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday. This will ensure smooth supply of Remdesivir across country so that no patient face difficulty in …

Doctors divided over use but scramble for Remdesivir continues
3 years, 8 months ago

Doctors divided over use but scramble for Remdesivir continues

The Hindu  

The scramble for Remdesivir, the anti-viral drug used in COVID-19 management, is increasing by the day even as doctors are divided on its use. Private Hospitals and Nursing Homes Association president H.M. Prasanna said that the helpline set up by the government is of little use. Manjunath, nodal officer for labs and testing in the State’s COVID-19 task force, said …

COVID: Remdesivir production expected to start in Wardha from Wednesday, says Nitin Gadkari
3 years, 8 months ago

COVID: Remdesivir production expected to start in Wardha from Wednesday, says Nitin Gadkari

India TV News  

Union minister Nitin Gadkari on Tuesday said Genetek LifeSciences will start production of remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday. Genetek LifeSciences, based in Wardha, has received loan licence to manufacture remdesivir injections. Gadkari also talked about steps taken to streamline oxygen supply in Nagpur and also expressed confidence that the recovery situation will improve …

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India
3 years, 8 months ago

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India

India TV News  

American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, the chief commercial officer of Gilead Sciences said on …

Russian firm awaits government approval to ship remdesivir to India
3 years, 8 months ago

Russian firm awaits government approval to ship remdesivir to India

India Today  

Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir antiviral drug to India by end-May to help fight a surge in Covid-19 cases there, once it has received the approval of Russia's government. The move comes soon after the drug's patent holder, US firm Gilead Sciences, filed a lawsuit …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting
3 years, 8 months ago

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting

News 18  

Amid a fight to acquire Remdesivir for ailing Covid-19 patients, a group of medical experts, professionals, and task-forces have stated that the injection can only be used inside a hospital setting. Maharashtra’s Covid-19 Task Force member Dr. Shashank Joshi took to Twitter to put out a statement saying that Remdesivir is not a ‘life-saving’ drug. The statement also made it …

Jharkhand seeks Centre's nod to import Remdesivir vials from Bangladesh
3 years, 8 months ago

Jharkhand seeks Centre's nod to import Remdesivir vials from Bangladesh

Hindustan Times  

With the increasing demand of Remdesivir for critical patients in Jharkhand, the state government sought permission from the Centre to import 50,000 vials of the Covid-19 drug from a Bangladeshi pharmaceuticals company. Chief Minister Hemant Soren on Sunday wrote a letter to Union Cabinet Minister DV Sadanand Gowda asking for permission to import the supply as soon as possible. We …

Why Indian doctors prescribe Remdesivir for Covid-19 despite negative global medical view
3 years, 8 months ago

Why Indian doctors prescribe Remdesivir for Covid-19 despite negative global medical view

India Today  

While a cacophony has broken out over the shortage of Remdesivir injections across the country, international health experts are wondering why it is so widely being prescribed in India. Dr Aviral Vatsa of the National Health Services Scotland said, “The UK guidelines, the Stanford US guidelines or even WHO guidelines have clearly said that there is no clear evidence any …

When Do You Really Need Remdesivir? Does It Work?
3 years, 8 months ago

When Do You Really Need Remdesivir? Does It Work?

The Quint  

Let’s go back to the basics. Remdesivir is an antiviral drug developed by American pharmaceutical giant Gilead Sciences. It was made to treat Hepatitis C and respiratory syncytial viruses over a decade ago, but it never got marketing approval. COVID-19 brought the drug back into the picture – and US President Trump offered Remdesivir to UK Prime Minister Boris Johnson, …

Covid-19: Pune asks Mumbai for 20,000 vials of Remdesivir amid vaccine shortage
3 years, 8 months ago

Covid-19: Pune asks Mumbai for 20,000 vials of Remdesivir amid vaccine shortage

India Today  

Pune Divisional Commissioner Saurabh Rao on Thursday requested the Brihanmumbai Municipal Corporation to spare 20,000 vials of Remdesivir from its stock of two lakh vials that it had procured recently. Rao wrote a letter to Municipal Commissioner Iqbal Chahal stating that there was an increasing demand for Remdesivir due to the spike in Covid-19 cases in Pune district. I am …

Amid Shortage, Remdesivir May Get Cheaper as Govt Says Manufacturers Offered to Cut Rate by Sunday
3 years, 8 months ago

Amid Shortage, Remdesivir May Get Cheaper as Govt Says Manufacturers Offered to Cut Rate by Sunday

News 18  

Several manufacturers of Remdesivir, that is being used in treatment of Covid-19, said they have ramped up production of the drug to meet its rising demand across the country. A Zydus Cadila spokesperson said, “The current spike in Covid-19 cases has led to a higher demand of Remdesivir. We are continuously monitoring the situation and working relentlessly to ensure patients …

Remdesivir: What is it and why is it being black marketed? All you need to know
3 years, 8 months ago

Remdesivir: What is it and why is it being black marketed? All you need to know

Op India  

In the last month, India went from reporting around 25,000+ Covid-19 cases to 1,85,000+ cases. In May 2020, the US Food and Drug Administration issued an emergency use authorisation for Remdesivir for the treatment of Covid-19 in adults and children hospitalised with severe disease. It may also help to conserve scarce health care resources, such as ventilators, during this pandemic.” …

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad
3 years, 8 months ago

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad

India TV News  

Amid a shortage of Remdesivir in Uttar Pradesh, Chief Minister Yogi Adityanath has directed the state health department to acquire 25,000 injections of Remdesivir from Gujarat's Ahmedabad on an urgent basis. In view of the sudden spike in demand due to the surge in COVID-19 cases, India has also banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients till …

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?
3 years, 8 months ago

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?

India Today  

Remdesivir, an injectable anti-viral drug repurposed for Covid-19 treatment, has been flying off the shelves of pharmacies over the last few weeks ever since India began reporting a steep rise in cases of the novel coronavirus. Remdesivir, which was cleared by the country's top drug regulator for restricted use in an emergency situation in June 2020, is being used in …

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO
3 years, 8 months ago

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO

India Today  

Amid the surge in demand for antiviral drug Remdesivir, the World Health Organization has said that there is still no evidence to suggest that the drug is useful in treating hospitalised Covid-19 patients. WHO's Chief Scientist Dr Soumya Swaminathan and its Technical Lead on Covid, Dr Maria Van Kerkhove on Monday told India Today TV that results from five clinical …

Coronavirus | India bans export of Remdesivir
3 years, 8 months ago

Coronavirus | India bans export of Remdesivir

The Hindu  

Centre has prohibited the exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients in an order issued on Sunday stating that there has been a sudden spike in demand for injection Remdesivir used in treatment of COVID patients. “India is witnessing a recent surge in COVID cases and there is a potential of further increase in demand for injection Remdesivir …

Discover Related